• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,617.37 93.11
( 0.13%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
63,697.20 -2,890.92
(-4.34%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
514.6538079
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
38.14
1266.71
EPS(TTM)
Face Value()
Div & Yield %
60.24
10
0
 

amaryug finance ltd
Veedol Corporation consolidated net profit declines 3.75% in the March 2026 quarter
May 21,2026
Net profit of Veedol Corporation declined 3.75% to Rs 57.46 crore in the quarter ended March 2026 as against Rs 59.70 crore during the previous quarter ended March 2025. Sales rose 14.04% to Rs 606.98 crore in the quarter ended March 2026 as against Rs 532.24 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.55% to Rs 191.62 crore in the year ended March 2026 as against Rs 168.75 crore during the previous year ended March 2025. Sales rose 9.96% to Rs 2168.54 crore in the year ended March 2026 as against Rs 1972.14 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales606.98532.24 14 2168.541972.14 10
OPM %10.3012.77 -10.479.94 -
PBDT73.4576.88 -4 272.58236.69 15
PBT63.9068.69 -7 238.43208.17 15
NP57.4659.70 -4 191.62168.75 14